Stocks · News reference
UBS analyst Joshua Spector maintains FMC (NYSE:FMC) with a Neutral and lowers the price target from $12 to $10.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Corteva (CTVA) surged 12% following a JPMorgan upgrade to Overweight with a $19 price target, implying 37% upside. The rally was fueled by the company's separation from Vylor and its inclusion in the S&P MidCap 400. Trading at 5.7x 2027 EBITDA, Corteva is positioned as a deep-value opportunity in crop protection, though legal liabilities from PFAS/PFOA concerns remain a risk factor.
Second global filing advances rimisoxafen as a novel weed control solution for Brazil's more than 70 million hectares of corn and soybeansFMC Corporation (NYSE:FMC), a leading global agricultural sciences company,
Analysts updated ratings and price targets for high-yield materials stocks Westlake, FMC and Mosaic, yielding 3.15%, 3.34% and 3.82%.